ROIV
Roivant Sciences Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$28.06
-0.49 ▼ -1.72%
🌙 3월 13일 6:23 PM ET (한국 3/14 07:23)
$28.61
+0.55 ▲ +1.96%
| Index | - | P/E | - | EPS (ttm) | -1.17 | Insider Own | 31.76% | Shs Outstand | 0.71B | Perf Week | -2.5% |
| Market Cap | 20.08B | Forward P/E | - | EPS next Y | -4.81% | Insider Trans | -11.28% | Shs Float | 0.49B | Perf Month | 4.7% |
| Enterprise Value | 16.36B | PEG | - | EPS next Q | -0.29 | Inst Own | 67.22% | Short Float | 4.8% | Perf Quarter | 38.64% |
| Income | -0.81B | P/S | 1508.83 | EPS this Y | -360.64% | Inst Trans | 1.53% | Short Ratio | 3.39 | Perf Half Y | 94.73% |
| Sales | 0.01B | P/B | 4.66 | EPS next 5Y | - | ROA | -14.69% | Short Interest | 23.46M | Perf YTD | 29.31% |
| Book/sh | 6.02 | P/C | 4.43 | EPS past 3/5Y | 42.73% -99.51% | ROE | -17.11% | 52W High | -7.48% ($30.33) | Perf Year | 169.29% |
| Cash/sh | 6.33 | P/FCF | - | Sales past 3/5Y | -19.3% - | ROIC | -18.53% | 52W Low | 221.42% ($8.73) | Perf 3Y | 258.37% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -751.06% | Gross Margin | 60.46% | Volatility(W/M) | 4.15% 3.52% | Perf 5Y | 182.44% |
| Dividend TTM | - | EV/Sales | 1229.44 | Sales Y/Y TTM | -86.36% | Oper. Margin | -9130.53% | ATR (14) | 1.12 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 30.66 | EPS Q/Q | -262.8% | Profit Margin | -6079.94% | RSI (14) | 53.99 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 30.66 | Sales Q/Q | -77.83% | SMA20 | -1.06% ($28.36) | Beta | 1.21 | Target Price | $34.2 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 2000000 | SMA50 | 11.46% ($25.17) | Rel Volume | 0.79 | Prev Close | $28.55 |
| Employees | 750 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 43.41% -60.65% | SMA200 | 58.03% ($17.76) | Avg Volume(3M) | 6.93M | Price | $28.06 |
| IPO | 2020/12/8 | Option/Short | Yes/Yes | Trades | 30840 | Volume | 5,466,843 | Change | -1.72% |
뉴스 로딩 중...